These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12121948)

  • 41. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Mehlhorn H; Dankert W; Hartman PG; Then RL
    Parasitol Res; 1995; 81(4):296-301. PubMed ID: 7624286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia.
    Walzer PD; Ashbaugh A
    Antimicrob Agents Chemother; 2002 Feb; 46(2):514-6. PubMed ID: 11796365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
    Hong YL; Hossler PA; Calhoun DH; Meshnick SR
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.
    Cushion MT; Walzer PD; Ashbaugh A; Rebholz S; Brubaker R; Vanden Eynde JJ; Mayence A; Huang TL
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2337-43. PubMed ID: 16801410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats.
    Schmatz DM; Powles MA; McFadden DC; Pittarelli L; Balkovec J; Hammond M; Zambias R; Liberator P; Anderson J
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1964-70. PubMed ID: 1416888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo.
    Bartlett MS; Current WL; Goheen MP; Boylan CJ; Lee CH; Shaw MM; Queener SF; Smith JW
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1811-6. PubMed ID: 8843286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
    Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
    J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The development of a new experimental model of pneumocystosis].
    Lavdovskaia MV; Kovalenko FP; Lysenko AIa; Strelkova MV; Chernov IuV
    Med Parazitol (Mosk); 1993; (5):26-34. PubMed ID: 8127267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Artificial infections of Pneumocystis carinii in the SCID mouse and their use in the in vivo evaluation of antipneumocystis drugs.
    Comley JC; Sterling AM
    J Eukaryot Microbiol; 1994; 41(6):540-6. PubMed ID: 7866380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental P. carinii pneumonia.
    Contini C; Angelici E; Canipari R
    J Antimicrob Chemother; 1999 Feb; 43(2):301-4. PubMed ID: 11252340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
    Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
    FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of a nested polymerase chain reaction for detecting Pneumocystis carinii from lung and blood in rat and human infection.
    Evans R; Joss AW; Pennington TH; Ho-Yen DO
    J Med Microbiol; 1995 Mar; 42(3):209-13. PubMed ID: 7884803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An improved rat model of Pneumocystis carinii pneumonia: induced infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    J Protozool; 1991; 38(6):138S-140S. PubMed ID: 1818140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii.
    Cushion MT; Collins M; Hazra B; Kaneshiro ES
    Antimicrob Agents Chemother; 2000 Mar; 44(3):713-9. PubMed ID: 10681344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.
    Walzer PD; Runck J; Steele P; White M; Linke MJ; Sidman CL
    Antimicrob Agents Chemother; 1997 Feb; 41(2):251-8. PubMed ID: 9021175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful treatment of Pneumocystis carinii Pneumonia in mice with benanomicin A (ME1451).
    Yasuoka A; Oka S; Komuro K; Shimizu H; Kitada K; Nakamura Y; Shibahara S; Takeuchi T; Kondo S; Shimada K
    Antimicrob Agents Chemother; 1995 Mar; 39(3):720-4. PubMed ID: 7793879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii.
    Atzori C; Bruno A; Chichino G; Bombardelli E; Scaglia M; Ghione M
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1492-6. PubMed ID: 8363381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dicationic diarylfurans as anti-Pneumocystis carinii agents.
    Boykin DW; Kumar A; Spychala J; Zhou M; Lombardy RJ; Wilson WD; Dykstra CC; Jones SK; Hall JE; Tidwell RR
    J Med Chem; 1995 Mar; 38(6):912-6. PubMed ID: 7699707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nude rats as a model of natural Pneumocystis carinii pneumonia: sequential morphological study of lung lesions.
    Pohlmeyer G; Deerberg F
    J Comp Pathol; 1993 Oct; 109(3):217-30. PubMed ID: 8300911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.